sutures newsletter

PRODUCED BY AND FOR MEMBERS OF THE DEPARTMENT OF SURGERY October 2014 | Archived Issues

FDA Warns About Extended-Release Opioid Products

Pharmacy Focus

The federal Food and Drug Administration has added a boxed warning to long-acting extended-release opioid products, noting an increased risk of opioid addiction, abuse and misuse, potentially leading to overdose and death. Serious, life-threatening or fatal respiratory depression may occur.


Mark Your Calendar


Surgery Grand Rounds

Click the "read more" to see information about upcoming Surgery Grand Rounds.


Grand Rounds

Click here to view a schedule of all upcoming grand rounds.


Educational Schedule

Click a PDF link below to see the Department of Surgery's educational schedule.

Educational Schedule - October 2014 (PDF)

Educational Schedule - November 2014 (PDF)


Surgery Scheduling

Click the "read more" for hours and contact information for surgery scheduling.

Share Your News

Know an interesting colleague we should profile? A story we should tell? Submit your ideas, meetings and events for consideration.

Click here to submit your news to Sutures

FDA Warns About Extended-Release Opioid Products

Pharmacy Focus

The federal Food and Drug Administration has added a boxed warning to long-acting extended-release opioid products, noting an increased risk of opioid addiction, abuse and misuse, potentially leading to overdose and death. Serious, life-threatening or fatal respiratory depression may occur.

Accidental ingestion of even one dose, especially by children, can result in a fatal overdose, the FDA said. Prolonged use during pregnancy can result in neonatal opioid withdrawal syndrome, which may be life-threatening if not recognized and treated. The syndrome requires management according to protocols developed by neonatology experts. 

Co-ingestion of alcohol may result in increased plasma levels and potentially fatal overdose, according to the FDA.

For more information, click here.